Table 4.

Examining the differences among participants who accessed the game and had good attention vs those who did not access the game and had poor attention.

Variables		Poor attention, did not access game	Good attention, accessed game	P value
n		39	117	—a
Behavioral intent, mean (SD)		0.17 (0.75)	0.25 (0.62)	.25
Misuse behavior, mean (SD)		0.05 (0.31)	0.09 (0.28)	.39
Misuse behavior 2, mean (SD)b		-0.08 (0.35)	0.09 (0.32)	.01
Misuse harm, mean (SD)		-0.04 (0.82)	0.22 (0.94)	.10
Narcan knowledge, mean (SD)		0.05 (0.28)	-0.04 (0.29)	.44
Opioid knowledge: harming teens, mean (SD)c		0.13 (0.41)	0.13 (0.41)	.99
Opioid knowledge, mean (SD)		0.09 (0.21)	0.06 (0.16)	.87
Perceived knowledge, mean (SD)		0.52 (1.13)	0.93 (1.00)	.05
Safe disposal, mean (SD)		0.09 (0.22)	0.08 (0.22)	.95
Safe storage, mean (SD)		0.05 (0.15)	0.03 (0.20)	.16
Self-efficacy: opioid safety, mean (SD)		0.14 (0.71)	0.39 (0.71)	.05
Self-efficacy: MUSE,d mean (SD)		-0.03 (0.81)	0.28 (0.60)	.01
Length of play, mean (SD)		7.02 (10.23)	20.22 (12.64)	.04
Number of levels played, mean (SD)		1.00 (0.00)	3.18 (1.54)	.01
Gender, n (%)					.42
	Female	15 (38.5)	57 (48.7)	—
	Male	23 (59.0)	59 (50.4)	—
	Nonbinary	1 (2.6)	1 (0.9)	—
Age, mean (SD)		14.90 (1.48)	14.62 (1.62)	.32
Race (grouping 1), n (%)					.07
	A: White or Caucasian	26 (66.7)	57 (48.7)	—
	B: Black or African American	8 (20.5)	23 (19.7)	—
	C: Hispanic or Latinx	5 (12.8)	23 (19.7)	—
	D: Other or missing	0 (0.0)	14 (12.0)	—
Race (grouping 2) = B: non-White, n (%)e		13 (33.3)	60 (51.3)	.05

^aNot applicable.

^bIndividual questions asking, “Is it okay to take someone else's opioid medication if you have had the same prescription in the past?”

^cIndividual questions asking, “Is the opioid crisis harming teenagers in the United States?”

^dMUSE: Medication Understanding and Use Self-Efficacy.

^eRace grouping 2 examines participants who selected “White” as one category and every other option as “non-White.”